Skip Navigation

Neuro-Oncology 2007 9(3):370-372; doi:10.1215/15228517-2007-008
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wavre, A.
Right arrow Articles by Ketterer, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wavre, A.
Right arrow Articles by Ketterer, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Society for Neuro-Oncology

Case study of intracerebral plasmacytoma as an initial presentation of multiple myeloma

Aurelia Wavre, Audrey S. Baur, Michael Betz, Dominique Mühlematter, Martine Jotterand, Khalil Zaman and Nicolas Ketterer

Department of Oncology (A.W., K.Z., N.K.), University Institute of Pathology (A.S.B.), Department of Radiotherapy (M.B.), and Service of Medical Genetics, University Hospital CHUV (D.M., M.J.), Lausanne; Switzerland

Address correspondence to Nicolas Ketterer, Pluridisciplinary Center for Oncology, CHUV, BH-06, Vaud, CH-1011 Lausanne, Switzerland (Nicolas.Ketterer{at}chuv.hospvd.ch).


   Abstract

Cerebral involvement is an uncommon complication of multiple myeloma. We report on a 64-year-old man hospitalized for a partial seizure. MRI showed two intracerebral lesions, which proved to be plasmacytomas. After complete staging, we retained the diagnosis of immunoglobulin G lambda-type multiple myeloma with CNS involvement. Cytogenetic analysis of plasma cells detected a deletion in the p53 gene at 17p13.1. Despite cranial radiotherapy and systemic chemotherapy, the patient's disease progressed rapidly and he died five months after diagnosis. What makes this case unusual is that overt multiple myeloma had been absent before cerebral involvement was discovered. It confirms the extremely poor prognosis of patients with CNS myeloma even in the presence of aggressive treatment. Cytogenetic abnormalities could be a marker of chromosomal and genetic instability, conferring to multiple myeloma a more aggressive profile.

Keywords: central nervous system involvement, multiple myeloma, p53 deletion

Received March 22, 2006; Accepted August 7, 2006


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.